-
Je něco špatně v tomto záznamu ?
Combining Donor Characteristics with Immunohistological Data Improves the Prediction of Islet Isolation Success
Z. Berkova, F. Saudek, P. Girman, K. Zacharovova, J. Kriz, E. Fabryova, I. Leontovyc, T. Koblas, L. Kosinova, T. Neskudla, E. Vavrova, D. Habart, S. Loukotova, M. Zahradnicka, K. Lipar, L. Voska, J. Skibova,
Jazyk angličtina Země Egypt
Typ dokumentu časopisecké články
PubMed
27803935
DOI
10.1155/2016/4214328
Knihovny.cz E-zdroje
- MeSH
- dárci tkání statistika a číselné údaje MeSH
- délka pobytu statistika a číselné údaje MeSH
- diabetes mellitus 1. typu chirurgie MeSH
- edém epidemiologie MeSH
- hospitalizace MeSH
- imunohistochemie MeSH
- index tělesné hmotnosti MeSH
- inzulin metabolismus MeSH
- Langerhansovy ostrůvky metabolismus chirurgie MeSH
- lidé MeSH
- pankreas MeSH
- retrospektivní studie MeSH
- studená ischemie statistika a číselné údaje MeSH
- transplantace Langerhansových ostrůvků metody MeSH
- vazokonstriktory terapeutické užití MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Variability of pancreatic donors may significantly impact the success of islet isolation. The aim of this study was to evaluate donor factors associated with isolation failure and to investigate whether immunohistology could contribute to organ selection. Donor characteristics were evaluated for both successful (n = 61) and failed (n = 98) islet isolations. Samples of donor pancreatic tissue (n = 78) were taken for immunohistochemical examination. Islet isolations with 250000 islet equivalents were considered successful. We confirmed that BMI of less than 25 kg/m(2) (P < 0.001), cold ischemia time more than 8 hours (P < 0.01), hospitalization longer than 96 hours (P < 0.05), higher catecholamine doses (P < 0.05), and edematous pancreases (P < 0.01) all unfavorably affected isolation outcome. Subsequent immunohistochemical examination of donor pancreases confirmed significant differences in insulin-positive areas (P < 0.001). ROC analyses then established that the insulin-positive area in the pancreas could be used to predict the likely success of islet isolation (P < 0.001). At the optimal cutoff point (>1.02%), sensitivity and specificity were 89% and 76%, respectively. To conclude, while the insulin-positive area, determined preislet isolation, as a single variable, is sufficient to predict isolation outcome and helps to improve the success of this procedure, its combination with the established donor scoring system might further improve organ selection.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023545
- 003
- CZ-PrNML
- 005
- 20200603140506.0
- 007
- ta
- 008
- 170720s2016 ua f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2016/4214328 $2 doi
- 035 __
- $a (PubMed)27803935
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ua
- 100 1_
- $a Berkova, Zuzana $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 245 10
- $a Combining Donor Characteristics with Immunohistological Data Improves the Prediction of Islet Isolation Success / $c Z. Berkova, F. Saudek, P. Girman, K. Zacharovova, J. Kriz, E. Fabryova, I. Leontovyc, T. Koblas, L. Kosinova, T. Neskudla, E. Vavrova, D. Habart, S. Loukotova, M. Zahradnicka, K. Lipar, L. Voska, J. Skibova,
- 520 9_
- $a Variability of pancreatic donors may significantly impact the success of islet isolation. The aim of this study was to evaluate donor factors associated with isolation failure and to investigate whether immunohistology could contribute to organ selection. Donor characteristics were evaluated for both successful (n = 61) and failed (n = 98) islet isolations. Samples of donor pancreatic tissue (n = 78) were taken for immunohistochemical examination. Islet isolations with 250000 islet equivalents were considered successful. We confirmed that BMI of less than 25 kg/m(2) (P < 0.001), cold ischemia time more than 8 hours (P < 0.01), hospitalization longer than 96 hours (P < 0.05), higher catecholamine doses (P < 0.05), and edematous pancreases (P < 0.01) all unfavorably affected isolation outcome. Subsequent immunohistochemical examination of donor pancreases confirmed significant differences in insulin-positive areas (P < 0.001). ROC analyses then established that the insulin-positive area in the pancreas could be used to predict the likely success of islet isolation (P < 0.001). At the optimal cutoff point (>1.02%), sensitivity and specificity were 89% and 76%, respectively. To conclude, while the insulin-positive area, determined preislet isolation, as a single variable, is sufficient to predict isolation outcome and helps to improve the success of this procedure, its combination with the established donor scoring system might further improve organ selection.
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a studená ischemie $x statistika a číselné údaje $7 D050377
- 650 _2
- $a diabetes mellitus 1. typu $x chirurgie $7 D003922
- 650 _2
- $a edém $x epidemiologie $7 D004487
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a inzulin $x metabolismus $7 D007328
- 650 _2
- $a Langerhansovy ostrůvky $x metabolismus $x chirurgie $7 D007515
- 650 _2
- $a transplantace Langerhansových ostrůvků $x metody $7 D016381
- 650 _2
- $a délka pobytu $x statistika a číselné údaje $7 D007902
- 650 _2
- $a pankreas $7 D010179
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a dárci tkání $x statistika a číselné údaje $7 D014019
- 650 _2
- $a vazokonstriktory $x terapeutické užití $7 D014662
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Saudek, Frantisek $u Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Girman, Peter $u Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Zacharovova, Klara $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Kriz, Jan $u Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Fabryova, Eva $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Leontovyc, Ivan $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Koblas, Tomas $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Kosinova, Lucie $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Neskudla, Tomas $u Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Vavrova, Ema $u Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Habart, David $u Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Loukotová, Šárka $u Laboratory of Pancreatic Islets, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0248561
- 700 1_
- $a Zahradnicka, Martina $u Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Lipar, Kvetoslav $u Transplant Surgery Department, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Voska, Ludek $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Skibova, Jelena $u Department of Medical Statistics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 773 0_
- $w MED00181720 $t Journal of diabetes research $x 2314-6753 $g Roč. 2016, č. - (2016), s. 4214328
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27803935 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20200603140503 $b ABA008
- 999 __
- $a ok $b bmc $g 1239226 $s 984458
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 2016 $c - $d 4214328 $e 20161010 $i 2314-6753 $m Journal of diabetes research $n J Diabetes Res $x MED00181720
- LZP __
- $a Pubmed-20170720